Medium-chain and short-chain saturated fatty acids are oxidized by soluble mitochondrial matrix enzymes
Book a free call with us to get started
Who is likely to benefit from GLP-1 and GIP therapy
Together, these rat studies suggest that the weight-lowering potential of GLP-1MK-801 is not associated with exacerbated nausea
Furthermore, NHEJ-mediated knock-in, including HITI, supports the insertion of large DNA fragments (up to ~50 kb), making it an exceptionally powerful tool for in vivo genome editing therapies 12
The cost of manufacturing GLP-1 anti-obesity drugs is low April 10, 2024 Source: Barber, MJ et al JAMA Network Open March 27, 2024 LINK (Calculated from the Appendix eTable 1 and eFigure 1, assuming the highest cost pens ($2.50 each) and doubling cost of API to account for wastage) New information about the potential medical benefits of GLP-1 medications tantalizes us